It has been revealed in a new report that Dr. Reddy's Laboratories has received the approval of the United States Food and Drug Administration for the release of its new generic drug for treating Parkinson's disease.
The drug ropinirole hydrochloride XR has been developed to cure the signs as well as symptoms of the illness. It is an extended version of the old medicine Requip XL manufactured by the company.
It has been found by IMS Health that Requip XL had a sale of nearly $58 million in the US last year ended March 2012. The drug is currently available in 30 count bottle sizes, says the report.
The new tablets are a registered trademark of pharma giant SmithKline Beecham, the company has affirmed. Launched on June 06, 2012, these tablets are available in the sizes of 2 mg, 4 mg, 6 mg, 8mg, and 12 mg.
The company had lately also launched a generic version of lansoprazole in the national market, which treats heartburns and acidity. The Ropinirole hydrochloride XR generic tablets are being believed to cut cases of Parkinson's disease in the nation, with an increase in company's sales.